<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M679</article-id>
      <article-id pub-id-type="publisher-id">molbank-2010-M679</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>(2<italic>E</italic>)-3-(3,5-Dimethyl-1-phenyl-1<italic>H</italic>-pyrazol-4-yl)-1-(2,5-dimethyl-3-thienyl)prop-2-en-1-one</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Asiri</surname>
            <given-names>Abdullah M.</given-names>
          </name>
          <xref rid="af1-molbank-2010-M679" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2010-M679" ref-type="aff">2</xref>
          <xref rid="c1-molbank-2010-M679" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>Salman A.</given-names>
          </name>
          <xref rid="af1-molbank-2010-M679" ref-type="aff">1</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2010-M679"><label>1</label>Chemistry Department, Faculty of Science, King Abdul Aziz University, P.O. Box 80203, Jeddah, Saudi Arabia</aff>
      <aff id="af2-molbank-2010-M679"><label>2</label>The Center of Excellence for Advanced Materials Research, King Abdul Aziz University, Jeddah, P.O. Box 80203, Saudi Arabia</aff>
      <author-notes>
        <corresp id="c1-molbank-2010-M679"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>aasiri2@kau.edu.sa</email>; Tel.: +966 2 6952293; Fax: +966 2 6952292.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>04</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="collection"><month>06</month>
        <year>2010</year>
      </pub-date>
      <volume>2010</volume>
      <issue>2</issue>
      <elocation-id>M679</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>03</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>04</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>The title compound, (2<italic>E</italic>)-3-(3,5-dimethyl-1-phenyl-1<italic>H</italic>-pyrazol-4-yl)-1-(2,5-dimethyl-3-thienyl)prop-2-en-1-one <bold>(3)</bold> was synthesized in high yield by aldol condensation of 3-acetyl-2,5-dimethylthiophene and 3,5-dimethyl-1-phenylpyrazole-4-carboxaldehyde in ethanolic NaOH at room temperature. Its structure was fully characterized by elemental analysis, IR, <sup>1</sup>H NMR, <sup>13</sup>C NMR and EI-MS spectral analysis.</p>
      </abstract>
      <kwd-group>
        <kwd>chalcone</kwd>
        <kwd>aldol condensation</kwd>
        <kwd>3-acetyl-2,5-dimethylthiophene</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Chalcones are open-chain flavonoids with a common skeleton of 1,3-diaryl-2-propen-1-one [<xref ref-type="bibr" rid="B1-molbank-2010-M679">1</xref>]. They possess a wide range of biological activities such as antioxidant [<xref ref-type="bibr" rid="B2-molbank-2010-M679">2</xref>], antibacterial [<xref ref-type="bibr" rid="B3-molbank-2010-M679">3</xref>], antidepressant [<xref ref-type="bibr" rid="B4-molbank-2010-M679">4</xref>], antihypertensive [<xref ref-type="bibr" rid="B5-molbank-2010-M679">5</xref>] and anti-inflammatory activity [<xref ref-type="bibr" rid="B6-molbank-2010-M679">6</xref>]. Transformation of chalcones into pyrazoline derivatives can dramatically increase their biological properties such as antibacterial [<xref ref-type="bibr" rid="B7-molbank-2010-M679">7</xref>], antiprotozoal [<xref ref-type="bibr" rid="B8-molbank-2010-M679">8</xref>], or anti-inflammatory [<xref ref-type="bibr" rid="B9-molbank-2010-M679">9</xref>] activities. On the basis of these aspects we have synthesized a novel pyrazoline-based chalcone from 3-acetyl-2,5-dimethylthiophene and 3,5-dimethyl-1-phenylpyrazole-4-carboxaldehyde.</p>
      <p>A solution of 3-acetyl-2,5-dimethylthiophene (0.38 g, 0.0025 mol) and 3,5-dimethyl-1-phenyl-pyrazole-4-carboxaldehyde (0.50 g, 0.0025 mol) in an ethanolic solution of NaOH (6.0 g in 10 mL of ethanol) was stirred for 16 h at room temperature. The solution was poured into ice-cold water of pH ~ 2 (pH adjusted by HCl). The solid was separated and dissolved in CH<sub>2</sub>Cl<sub>2</sub>, this solution was washed with a saturated solution of NaHCO<sub>3</sub> and then evaporated to dryness. The residue was recrystallized from methanol/chloroform.</p>
      <p>Light-yellow solid: yield: 78%; m.p. 111&#x2013;112 &#xB0;C.</p>
      <p>EI-MS <italic>m/z</italic> (rel. int.%): 337 (65) [M+1]<sup>+</sup>,</p>
      <p>IR (KBr) <italic>v</italic><sub>max</sub> cm<sup>&#x2013;1</sup>: 3055 (Ar-H), 2918 (C-H), 1642 (C=O), 1575 (C=C).</p>
      <p><sup>1</sup>H NMR (DMSO-<italic>d</italic><sub>6</sub>) (&#x3B4;/ppm): 7.71 (d, 1H, <italic>J</italic> = 16.2 Hz, 8-C<italic>H</italic>), 7.35 (d, 1H, <italic>J</italic> = 16.0 Hz, 7-C<italic>H</italic>), 7.19 (s, 1H, thiophene 4-H), 7.24&#x2013;6.93 (m, 5H, Ph), 2.65 (s, 3H, pyrazole 3-CH<sub>3</sub>), 2.44 (s, 3H, pyrazole 5-CH<sub>3</sub>), 2.37 (s, 3H, thiophene 2-CH<sub>3</sub>), 2.36 (s, 3H, thiophene 5-CH<sub>3</sub>).</p>
      <p><sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) &#x3B4;: 185.43 (CO), 150.79 (10-C), 145.59, 140.04, 137.90, 136.00, 134.25, 133.86, 128.32, 127.74, 124.82, 123.89, 117.92, 114.32, 28.67, 14.92, 13.94, 11.96, 10.62. </p>
      <p>Anal. calc. for C<sub>20</sub>H<sub>20</sub>N<sub>2</sub>OS: C, 71.40, H, 5.99, N, 8.33. Found: C, 71.36, H, 5.95, N, 8.28.</p>
  </body>
  <back>
  <app-group>
  <app id="app1-molbank-2010-M679">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2010-M679-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M679-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2010-M679-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M679-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors would like to thank the Chemistry Department, King Abdul Aziz University, Jeddah, Saudi Arabia for providing the research facilities and the deanship of scientific research for the financial support of this work via Grant No. (3-045/430). </p>
    </ack>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2010-M679">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Batovska</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Parushev</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Stamboliyska</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Tsvetkova</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Ninova</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Najdenski</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2009</year>
          <volume>44</volume>
          <fpage>2211</fpage>
          <lpage>2218</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2008.05.010</pub-id>
          <pub-id pub-id-type="pmid">18584918</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2010-M679">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bandgar</surname>
              <given-names>B.P.</given-names>
            </name>
            <name>
              <surname>Gawande</surname>
              <given-names>S.S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biological screening of a combinatorial library of &#x3B2;-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents</article-title>
          <source>Bior. Med. Chem.</source>
          <year>2010</year>
          <volume>18</volume>
          <fpage>2060</fpage>
          <lpage>2065</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2009.12.077</pub-id>
          <pub-id pub-id-type="pmid">20138527</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2010-M679">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nielsen</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Boesen</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Schonning</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kromann</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Antibacterial chalcones &#x2013;bioisosteric replacement of the 4&#x2032;-hydroxy group</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2004</year>
          <volume>12</volume>
          <fpage>3047</fpage>
          <lpage>3054</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2004.03.071</pub-id>
          <pub-id pub-id-type="pmid">15142563</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2010-M679">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozdemir</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Kandilci</surname>
              <given-names>H.B.</given-names>
            </name>
            <name>
              <surname>Gumusel</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Cal&#x131;s</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Bilgin</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2007</year>
          <volume>42</volume>
          <fpage>373</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2006.09.006</pub-id>
          <pub-id pub-id-type="pmid">17069933</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2010-M679">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ansari</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Iftikhar</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ihsan-ul-Haq</surname>
            </name>
            <name>
              <surname>Mirza</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Baseer</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Rashid</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Solid-phase synthesis and biological evaluation of a parallel library of 2,3-dihydro-1,5-benzothiazepines</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2008</year>
          <volume>16</volume>
          <fpage>7691</fpage>
          <lpage>7697</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2008.07.009</pub-id>
          <pub-id pub-id-type="pmid">18650096</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2010-M679">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asiri</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>(2<italic>E</italic>,2'<italic>E</italic>)-3,3-(1,4-Phenylene)bis[1-(2,5-dimethyl-3-thienyl)prop-2-en-1-one]</article-title>
          <source>Molbank</source>
          <year>2009</year>
          <volume>2009</volume>
          <fpage>M636</fpage>
          <pub-id pub-id-type="doi">10.3390/M636</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2010-M679">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holla</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Akberali</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Shivananda</surname>
              <given-names>M.K.</given-names>
            </name>
          </person-group>
          <article-title>Studies on arylfuran derivatives: Part X. Synthesis and antibacterial properties of arylfuryl-&#x394;<sup>2</sup>-pyrazolines</article-title>
          <source>Il Farmaco</source>
          <year>2000</year>
          <volume>55</volume>
          <fpage>256</fpage>
          <lpage>263</lpage>
          <pub-id pub-id-type="pmid">10966156</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2010-M679">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chimenti</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bizzarri</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Manna</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bolasco</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Secci</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Chimenti</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Granese</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rivanera</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lilli</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Scaltrito</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Brenciaglia</surname>
              <given-names>M.I.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and in vitro selective anti-<italic>Helicobacter pylori</italic> activity of pyrazoline derivatives</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>603</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2004.11.042</pub-id>
          <pub-id pub-id-type="pmid">15664821</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2010-M679">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manna</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Chimenti</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bolasco</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cenicola</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Amico</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Parrillo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Marmo</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Anti-inflammatory, analgesic and antipyretic N-acetyl-&#x394;<sup>2</sup>-pyrazolines and dihydro-thienocoumarines</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>1992</year>
          <volume>27</volume>
          <fpage>633</fpage>
          <lpage>639</lpage>
          <pub-id pub-id-type="doi">10.1016/0223-5234(92)90142-N</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Figure</title>
      <fig id="molbank-2010-M679-f001" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Synthesis of compound <bold>3</bold>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M679-g001.tif"/>
      </fig>
    </sec>
  </back>
</article>
